iCAD develops artificial intelligence solutions for cancer detection, specifically focusing on breast cancer screening and assessment. The company provides AI-powered tools for detection, density assessment, and risk evaluation.

iCAD

icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.

COM:ICADMED

iCAD

Last Close

1.54

22/11 21:00

Market Cap

40.59M

Beta: -

Volume Today

171.23K

Avg: -

Analysis Not Available